Role of Topoisomerases in Pediatric High Grade Osteosarcomas: TOP2A Gene Is One of the Unique Molecular Biomarkers of Chemoresponse

Inhibition of the Wnt-β-catenin and Notch signaling pathways sensitizes osteosarcoma cells to chemotherapy

(2013) Yimin Ma et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Topoisomerase 2 alpha: a real predictor of anthracycline efficacy?

(2012) Atocha Romero et al.   Clinical & Translational Oncology

The prognostic value of elevated vascular endothelial growth factor in patients with osteosarcoma: a meta-analysis and systemic review

(2012) Jin-tao Qu et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Predicting chemosensitivity in osteosarcoma prior to chemotherapy: An investigational study of biomarkers with immunohistochemistry

(2012) YONG CHEN et al.   Oncology Letters

Assessment of Topoisomerase II α Status in Breast Cancer by Quantitative PCR, Gene Expression Microarrays, Immunohistochemistry, and Fluorescence in Situ Hybridization

(2011) Atocha Romero et al.   AMERICAN JOURNAL OF PATHOLOGY

Topoisomerase II Alpha and Responsiveness of Breast Cancer to Adjuvant Chemotherapy

(2009) F. P. O'Malley et al.   JNCI-Journal of the National Cancer Institute

The value ofTOP2Agene copy number variation as a biomarker in breast cancer: Update of DBCG trial 89D

(2008) Kirsten Vang Nielsen et al.   ACTA ONCOLOGICA